Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three
and nine months ended December 27, 2020, its third quarter of
fiscal 2021. Highlights include:
- Record third quarter sales of $142.9 million, a 19%
year-over-year increase, with a 75% year-over-year sales increase
in our Health and Nutrition segment.
- Record third quarter gross profit of $28.2 million, a 31%
increase over the prior year, contributing to a 55% year-over-year
increase in operating income.
- Third quarter diluted earnings per share (EPS) of $0.75, which
was $0.32, or 74%, higher than the same period last year.
- Year to date diluted EPS of $3.00, a 35% increase over the
prior year.
- Net debt of $88 million and a leverage ratio of 1.2x, while
reinitiating stock repurchases in the third quarter.
- Extended our Water Treatment footprint into Louisiana through
the acquisition of C & L Aqua Professionals, Inc. and LC
Blending, Inc. on December 30, 2020.
Executive Commentary – Patrick H. Hawkins, Chief
Executive Officer and President:
“We are very pleased with our company’s continued growth in net
income this quarter. We have continued to operate and execute on
our business strategy throughout this pandemic, and our business
segment operating results reflected substantial year-over-year
improvement in the third quarter. In particular, our Health and
Nutrition segment reported revenue growth of 75% over the same
period last year, with operating income growing to nearly six times
the levels of last year due to increased demand for health and
immunity products. In our Water Treatment segment, our acquisition
of American Development Corporation has been accretive, and while
we've seen some areas of softness in our legacy business, which we
believe is related to COVID-19 impacts, increased sales of our
specialty and manufactured products contributed to the
year-over-year increase. Our Industrial segment reported
year-over-year sales growth in the third quarter for the first time
this year, with gross profit increasing nearly 10% as a result of
increased sales of our specialty and manufactured products."
Mr. Hawkins continued, "As previously announced, we extended our
Water Treatment footprint into the state of Louisiana with
acquisitions at the end of December, and look forward to continuing
to grow our business as a result. In addition, we acquired a
manufacturing facility to allow further expansion and growth in
both our Industrial and Water Treatment segments. This site is
adjacent to our facility in Rosemount, Minnesota, adding 40,000
square feet of manufacturing and warehouse space on 28 acres of
land to bring us to a total of 105,000 square feet of space on 56
acres of land in that area, with rail access at both of the sites
to allow for future growth and provide for supply chain flexibility
on certain raw materials to better serve our customers. These
actions reaffirm our deep commitment to continue to grow the
business.”
Third Quarter Financial
Highlights:
Sales were $142.9 million for the third quarter of fiscal 2021,
an increase of 19%, from sales of $120.4 million for the same
period of the prior year. Industrial segment sales increased $1.4
million, or 2%, to $64.4 million for the current quarter, as
compared to $63.0 million for the same period of the prior year.
The increase in sales dollars from the prior year was driven
largely by a product mix shift of more sales of certain of our
higher-priced manufactured, blended and repackaged products. Water
Treatment segment sales increased $4.4 million, or 13%, to $39.3
million for the current quarter, as compared to $34.9 million for
the same period of the prior year. The increase in sales dollars
from the prior year was largely attributable to added sales from
the acquisition of ADC. Sales by our legacy business also increased
overall due to increased sales of our manufactured, blended and
repackaged products. Sales for our Health and Nutrition segment
increased $16.8 million, or 75%, to $39.3 million for the current
quarter, as compared to $22.5 million for the same period of the
prior year. The increase in sales was driven by increased sales of
both our manufactured and specialty distributed products largely as
a result of increased consumer demand for health and immunity
products.
Gross profit increased $6.7 million, or 31%, to $28.2 million,
or 20% of sales, for the current quarter, from $21.5 million, or
18% of sales, for the same period a year ago. During the current
quarter, the LIFO reserve increased, and gross profits decreased,
by $0.1 million. In the same quarter a year ago, the LIFO reserve
decreased, and gross profits increased, by $0.3 million. Gross
profit for the Industrial segment increased $0.8 million, or 9%, to
$9.2 million, or 14% of sales, for the current quarter, from $8.4
million, or 13% of sales, for the same period of the prior year.
Total Industrial segment gross profit, and gross profit as a
percentage of sales, increased due to a product mix shift to more
sales of certain higher-margin manufactured, blended and
re-packaged products. Gross profit for the Water Treatment segment
increased $1.6 million to $10.0 million, or 26% of sales, for the
current quarter, from $8.4 million, or 24% of sales, for the same
period of the prior year. Gross profit in our Water Treatment
segment increased as a result of the added gross profit from the
sales in the acquired ADC business, as well as increased sales of
manufactured, blended and repackaged products in our legacy
business. Gross profit for our Health and Nutrition segment
increased $4.3 million, or 92%, to $9.0 million, or 23% of sales,
for the current quarter, from $4.7 million, or 21% of sales, for
the same period of the prior year. Gross profit in our Health and
Nutrition segment increased as a result of higher sales compared to
the prior year.
Company-wide selling, general and administrative expenses
increased $3.1 million to $17.8 million, or 12% of sales, for the
current quarter, compared to $14.7 million, or 12% of sales, for
the same period of the prior year. Expenses increased primarily due
to an increase in variable costs, primarily variable compensation,
added costs from the acquired ADC business, including amortization
of intangibles, and acquisition expenses. In addition, we recorded
a year-over-year expense increase of $0.3 million due to higher
compensation expense relating to the non-qualified deferred
compensation plan liability which is offset in other income as
described below. These increases were partially offset by a
decrease in travel and trade show expenses due to restrictions
imposed as a result of COVID-19.
Our effective income tax rate was 25.2% for the current quarter,
compared to 28.1% in the same period of the prior year. The
effective tax rate decreased from the prior year due to favorable
tax provision adjustments recorded in the third quarter of fiscal
2021. The effective tax rate is impacted by projected levels of
annual taxable income, permanent items, and state taxes.
Earnings before interest, taxes, depreciation and amortization
("EBITDA"), a non-GAAP financial measure, is an important
performance indicator and a key compliance measure under the terms
of our credit agreement. An explanation of the computation of
EBITDA is presented below. EBITDA for the three months ended
December 27, 2020 was $17.8 million, an increase of $4.8
million, or 37%, from EBITDA of $13.0 million for the same period
of the prior year. The increase was primarily due to improved gross
profit.
About Hawkins, Inc.
Hawkins, Inc. was founded in 1938 and is a leading specialty
chemical company that distributes, blends and manufactures
chemicals and other specialty ingredients for its Industrial, Water
Treatment, and Health & Nutrition customers. Headquartered in
Roseville, Minnesota, and with 46 facilities in 21 states, the
Company creates value for its customers through superb customer
service and support, quality products and personalized
applications. Hawkins, Inc. generated $540 million of revenue in
fiscal 2020 and has approximately 700 employees. For more
information, including registering to receive email alerts, please
visit www.hawkinsinc.com/investors.
Reconciliation of Non-GAAP Financial Measures
We report our consolidated financial results in accordance with
U.S. generally accepted accounting principles (GAAP). To assist
investors in understanding our financial performance between
periods, we have provided certain financial measures not computed
according to GAAP, including adjusted EBITDA. This non-GAAP
financial measure is not meant to be considered in isolation or as
a substitute for comparable GAAP measures. The method we use to
produce non-GAAP results is not computed according to GAAP and may
differ from the methods used by other companies.
Management uses this non-GAAP financial measure internally to
understand, manage and evaluate our business and to make operating
decisions. Management believes that this non-GAAP financial measure
reflects an additional way of viewing aspects of our operations
that, when viewed with our GAAP results, provides a more complete
understanding of the factors and trends affecting our financial
condition and results of operations.
We define adjusted EBITDA as GAAP net income adjusted for the
impact of the following: net interest expense resulting from our
net borrowing position; income tax expense; non-cash expenses
including amortization of intangibles, depreciation and charges for
the employee stock purchase plan and restricted stock grants; and
non-recurring items of income or expense, if applicable.
|
Adjusted
EBITDA |
Three Months Ended |
|
Nine months ended |
(In thousands) |
December 27, 2020 |
|
December 29, 2019 |
|
December 27, 2020 |
|
December 29, 2019 |
Net Income
(GAAP) |
$ |
7,921 |
|
|
$ |
4,547 |
|
|
$ |
31,899 |
|
|
$ |
23,604 |
|
Interest expense, net |
382 |
|
|
584 |
|
|
1,101 |
|
|
2,013 |
|
Income tax expense |
2,664 |
|
|
1,776 |
|
|
11,285 |
|
|
8,571 |
|
Amortization of intangibles |
1,521 |
|
|
1,268 |
|
|
4,237 |
|
|
3,805 |
|
Depreciation expense |
4,149 |
|
|
4,174 |
|
|
12,498 |
|
|
12,376 |
|
Non-cash compensation expense |
917 |
|
|
685 |
|
|
2,303 |
|
|
1,830 |
|
Non-recurring acquisition expenses |
243 |
|
|
— |
|
|
508 |
|
|
— |
|
Adjusted
EBITDA |
$ |
17,797 |
|
|
$ |
13,034 |
|
|
$ |
63,831 |
|
|
$ |
52,199 |
|
|
|
HAWKINS,
INC.CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)(In thousands, except share and
per-share data)
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
December 27, 2020 |
|
December 29, 2019 |
|
December 27, 2020 |
|
December 29, 2019 |
Sales |
|
$ |
142,927 |
|
|
|
$ |
120,406 |
|
|
|
$ |
433,900 |
|
|
|
$ |
407,785 |
|
Cost of sales |
|
(114,688 |
) |
|
|
(98,928 |
) |
|
|
(341,888 |
) |
|
|
(329,516 |
) |
Gross profit |
|
28,239 |
|
|
|
21,478 |
|
|
|
92,012 |
|
|
|
78,269 |
|
Selling, general and
administrative expenses |
|
(17,750 |
) |
|
|
(14,702 |
) |
|
|
(49,009 |
) |
|
|
(44,355 |
) |
Operating income |
|
10,489 |
|
|
|
6,776 |
|
|
|
43,003 |
|
|
|
33,914 |
|
Interest expense, net |
|
(382 |
) |
|
|
(584 |
) |
|
|
(1,101 |
) |
|
|
(2,013 |
) |
Other income |
|
478 |
|
|
|
131 |
|
|
|
1,282 |
|
|
|
274 |
|
Income before income taxes |
|
10,585 |
|
|
|
6,323 |
|
|
|
43,184 |
|
|
|
32,175 |
|
Income tax expense |
|
(2,664 |
) |
|
|
(1,776 |
) |
|
|
(11,285 |
) |
|
|
(8,571 |
) |
Net income |
|
$ |
7,921 |
|
|
|
$ |
4,547 |
|
|
|
$ |
31,899 |
|
|
|
$ |
23,604 |
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares
outstanding - basic |
|
10,506,918 |
|
|
|
10,546,453 |
|
|
|
10,521,521 |
|
|
|
10,575,432 |
|
Weighted average number of shares
outstanding - diluted |
|
10,611,655 |
|
|
|
10,605,895 |
|
|
|
10,639,372 |
|
|
|
10,656,115 |
|
Basic earnings per share |
|
$ |
0.75 |
|
|
|
$ |
0.43 |
|
|
|
$ |
3.03 |
|
|
|
$ |
2.23 |
|
Diluted earnings per share |
|
$ |
0.75 |
|
|
|
$ |
0.43 |
|
|
|
$ |
3.00 |
|
|
|
$ |
2.22 |
|
Cash dividends declared per
common share |
|
$ |
0.2325 |
|
|
|
$ |
0.2300 |
|
|
|
$ |
0.6975 |
|
|
|
$ |
0.6900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HAWKINS, INC.CONDENSED
CONSOLIDATED BALANCE SHEETS (UNAUDITED)(In
thousands, except share data)
|
|
December 27,2020 |
|
March 29,2020 |
ASSETS |
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
Cash and cash equivalents |
|
$ |
7,969 |
|
|
$ |
4,277 |
|
Trade receivables — less allowance for doubtful accounts: $549 as
of December 27, 2020 and $784 as of March 29, 2020 |
|
76,822 |
|
|
67,391 |
|
Inventories |
|
64,657 |
|
|
54,436 |
|
Income taxes receivable |
|
946 |
|
|
— |
|
Prepaid expenses and other current assets |
|
5,075 |
|
|
4,927 |
|
Total current assets |
|
155,469 |
|
|
131,031 |
|
PROPERTY, PLANT, AND
EQUIPMENT: |
|
291,491 |
|
|
267,221 |
|
Less accumulated depreciation |
|
152,568 |
|
|
140,877 |
|
Net property, plant, and equipment |
|
138,923 |
|
|
126,344 |
|
OTHER ASSETS: |
|
|
|
|
Right-of-use assets |
|
8,181 |
|
|
9,090 |
|
Goodwill |
|
67,657 |
|
|
58,440 |
|
Intangible assets, net of accumulated amortization |
|
69,726 |
|
|
60,653 |
|
Other |
|
6,049 |
|
|
3,770 |
|
Total other assets |
|
151,613 |
|
|
131,953 |
|
Total assets |
|
$ |
446,005 |
|
|
$ |
389,328 |
|
LIABILITIES AND
SHAREHOLDERS’ EQUITY |
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
Accounts payable — trade |
|
$ |
31,160 |
|
|
$ |
34,129 |
|
Accrued payroll and employee benefits |
|
13,406 |
|
|
13,538 |
|
Current portion of long-term debt |
|
9,907 |
|
|
9,907 |
|
Short-term lease liability |
|
1,440 |
|
|
1,523 |
|
Container deposits |
|
1,426 |
|
|
1,376 |
|
Other current liabilities |
|
1,693 |
|
|
1,747 |
|
Total current liabilities |
|
59,032 |
|
|
62,220 |
|
LONG-TERM DEBT, LESS CURRENT
PORTION |
|
85,821 |
|
|
49,751 |
|
LONG-TERM LEASE LIABILITY |
|
6,854 |
|
|
7,649 |
|
PENSION WITHDRAWAL
LIABILITY |
|
4,719 |
|
|
4,978 |
|
DEFERRED INCOME TAXES |
|
25,097 |
|
|
25,106 |
|
DEFERRED COMPENSATION
LIABILITY |
|
7,054 |
|
|
5,026 |
|
OTHER LONG-TERM
LIABILITIES |
|
514 |
|
|
1,114 |
|
Total liabilities |
|
189,091 |
|
|
155,844 |
|
COMMITMENTS AND
CONTINGENCIES |
|
— |
|
|
— |
|
SHAREHOLDERS’ EQUITY: |
|
|
|
|
Common stock; authorized: 30,000,000 shares of $0.05 par value;
10,462,159 and 10,512,229 shares issued and outstanding as of
December 27, 2020 and March 29, 2020, respectively |
|
523 |
|
|
526 |
|
Additional paid-in capital |
|
48,975 |
|
|
50,090 |
|
Retained earnings |
|
207,416 |
|
|
182,947 |
|
Accumulated other comprehensive loss |
|
— |
|
|
(79 |
) |
Total shareholders’ equity |
|
256,914 |
|
|
233,484 |
|
Total liabilities and shareholders’ equity |
|
$ |
446,005 |
|
|
$ |
389,328 |
|
|
|
HAWKINS, INC.CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)(In thousands)
|
|
Nine Months Ended |
|
|
December 27,2020 |
|
December 29,2019 |
CASH FLOWS FROM OPERATING
ACTIVITIES: |
|
|
|
|
Net income |
|
$ |
31,899 |
|
|
$ |
23,604 |
|
Reconciliation to cash flows: |
|
|
|
|
Depreciation and amortization |
|
16,735 |
|
|
16,181 |
|
Operating leases |
|
1,419 |
|
|
1,538 |
|
Gain on deferred compensation assets |
|
(1,282 |
) |
|
(274 |
) |
Stock compensation expense |
|
2,303 |
|
|
1,830 |
|
Other |
|
170 |
|
|
(42 |
) |
Changes in operating accounts providing (using)
cash: |
|
|
|
|
Trade receivables |
|
(8,121 |
) |
|
8,035 |
|
Inventories |
|
(9,431 |
) |
|
2,940 |
|
Accounts payable |
|
(3,569 |
) |
|
(2,469 |
) |
Accrued liabilities |
|
1,160 |
|
|
(3,148 |
) |
Lease liabilities |
|
(1,363 |
) |
|
(1,565 |
) |
Income taxes |
|
(1,006 |
) |
|
(82 |
) |
Other |
|
(2,308 |
) |
|
(1,557 |
) |
Net cash
provided by operating activities |
|
26,606 |
|
|
44,991 |
|
CASH FLOWS FROM INVESTING
ACTIVITIES: |
|
|
|
|
Purchases of property, plant, and equipment |
|
(13,200 |
) |
|
(19,426 |
) |
Acquisitions, net of cash acquired |
|
(35,017 |
) |
|
— |
|
Other |
|
154 |
|
|
326 |
|
Net cash
used in investing activities |
|
(48,063 |
) |
|
(19,100 |
) |
CASH FLOWS FROM FINANCING
ACTIVITIES: |
|
|
|
|
Cash dividends declared and paid |
|
(7,430 |
) |
|
(7,350 |
) |
New shares issued |
|
773 |
|
|
661 |
|
Shares surrendered for payroll taxes |
|
(54 |
) |
|
(343 |
) |
Shares repurchased |
|
(4,140 |
) |
|
(3,793 |
) |
Net
proceeds from (payments on) revolving loan |
|
36,000 |
|
|
(17,000 |
) |
Net cash provided by (used in) financing activities |
|
25,149 |
|
|
(27,825 |
) |
NET INCREASE (DECREASE) IN CASH
AND CASH EQUIVALENTS |
|
3,692 |
|
|
(1,934 |
) |
CASH AND CASH EQUIVALENTS,
BEGINNING OF PERIOD |
|
4,277 |
|
|
9,199 |
|
CASH AND CASH EQUIVALENTS, END OF
PERIOD |
|
$ |
7,969 |
|
|
$ |
7,265 |
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURES OF CASH
FLOW INFORMATION |
|
|
|
|
Cash paid for income taxes |
|
$ |
12,345 |
|
|
$ |
8,653 |
|
Cash paid for interest |
|
$ |
893 |
|
|
$ |
1,960 |
|
Noncash investing activities - capital expenditures in accounts
payable |
|
$ |
790 |
|
|
$ |
394 |
|
|
|
|
|
|
|
|
|
|
Forward-Looking Statements. Various remarks in this press
release constitute forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. These
statements include those relating to impact and duration of wage
pressures, the levels of investment and the impact of investments
on our business operations and financial condition, the timing of
new Water Treatment branch investments, and the duration and impact
of product shortages. These statements are not historical facts,
but rather are based on our current expectations, estimates and
projections, and our beliefs and assumptions. Forward-looking
statements may be identified by terms, including “anticipate,”
“believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,”
“should,” or “will” or the negative of these terms or other
comparable terms. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and
other factors, some of which are beyond our control and are
difficult to predict. Actual results may vary materially from those
contained in forward looking statements based on a number of
factors, including, but not limited to, the impact and severity of
the COVID-19 outbreak, changes in the labor markets, our available
cash for investments, our business capital needs, changes in
competition and price pressure, changes in demand and customer
requirements or processes for our products, interruptions in
production resulting from hazards, transportation limitations or
other extraordinary events outside our control that may negatively
impact our business or the supply chains in which we participate,
our ability to locate suitable real estate for new branch
additions, changes in imported products and tariff levels, the
availability of products and the prices at which they are
available, the acceptance of new products by our customers and the
timing of any such acceptance, and changes in product supplies.
Additional information concerning potential factors that could
affect future financial results is included in our Annual Report on
Form 10-K for the fiscal year ended March 29, 2020, as updated from
time to time in amendments and subsequent reports filed with the
SEC. Investors should take such risks into account when making
investment decisions. Shareholders and other readers are cautioned
not to place undue reliance on forward-looking statements, which
reflect our management’s view only as of the date hereof. We do not
undertake any obligation to update any forward-looking
statements.
Contacts: |
Jeffrey P. Oldenkamp |
|
Executive Vice President and Chief Financial Officer |
|
612/617-8571 |
|
Jeff.Oldenkamp@HawkinsInc.com |
Hawkins (NASDAQ:HWKN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hawkins (NASDAQ:HWKN)
Historical Stock Chart
From Apr 2023 to Apr 2024